CARDIFF ONCOLOGY, INC. Shares Issued for Acquisitions
CARDIFF ONCOLOGY, INC. (CRDF) reported Shares Issued for Acquisitions of 125.00 thousand shares for the 155-month period ending 2012-06-30, per its 10-Q filed 2012-08-14.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesAcquisitions · last filed 2012-08-14
- 2012-06-30: Stock Issued During Period, Shares, Acquisitions 6 month 125.00K shares; Stock Issued During Period, Shares, Acquisitions 155 month 125.00K shares.
| Period end | Stock Issued During Period, Shares, Acquisitions 6 month | Stock Issued During Period, Shares, Acquisitions 155 month |
|---|---|---|
| 2012-06-30 | 125.00K shares 10-Q · filed 2012-08-14 | 125.00K shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |